#XSeedLabs
@BioMedXInst & @Boehringer invite researchers to develop next-gen intraocular biologics at #XSeedLabs (CT, USA) to reduce the burden of frequent injections in #retinal disease.
Apply by July 12 👉 career.bmedx.com/call/2025-RD...
#biologics #ophthalmology #pharma
BioMed X Institute
BioMed X Application System
career.bmedx.com
May 22, 2025 at 11:24 AM